The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
To find out more about the study, please visit our main site.
Latest blog posts
Join us at the BSR Annual Conference, 28-30 April 2025!
#BSR25 We are thrilled that we will be at the BSR’s Annual Conference next month. This conference offers a wide variety of talks across all aspects of rheumatology and rheumatology research. We are pleased that we will be attending and have the opportunity to meet...
Meet a Register Champion
Introducing Anne-Marie, one of our fantastic register champions on the BSRBR-RA Study. We asked Anne-Marie some questions on how she recruits participants successfully, and how she stays on top of the follow ups. How do you identify eligible participants for BSRBR-RA?...
International Women’s Day – Women in Science
To continue our focus on inspirational women in science, to celebrate International Women's Day, we asked BSRBR-RA Chief Investigator, Professor Kimme Hyrich, about her route to research. What did you study at which University? I grew up in Canada and did most of my...
International Women’s Day – Women in Science
To celebrate International Women's Day, we spoke to one of our inspirational colleagues, Dr Lianne Kearsley-Fleet. Lianne has published many research papers on BSRBR-RA data, and is now Co-Lead Investigator with the UK JIA Biologics Register. We asked her some...
BSRBR-RA Recruitment Workshop – 11th February 2025
We recently held a workshop for our NHS healthcare professional colleagues involved in the BSRBR-RA Study around the topic of Recruitment. We wanted to find out what really works in terms of recruiting participants to the study and to share good practice across...
Patient follow-up questionnaires
We recently launched our online system for collecting patient data. This is a new exciting development for us and we are thrilled that we have been able to start sending questionnaires to our study participants.How it worksThe participant consents to the study and...
The impact of your data
Have you ever wondered where the data you provide are used?Whether you are a participant in the study, or an NHS professional who provides the data to BSRBR-RA, the answer is the same. This data is vital in the ongoing research into the long-term safety of biologic,...
BSRBR-RA Review of 2024
2024 has been another great year for BSRBR-RA. We’re very grateful to the NHS professionals who provide data, and to the participants. The data provided is integral to the success of the research.Our year in numbersOur publications this year Association between body...
How body weight affects the way people with rheumatoid arthritis react to treatment with tocilizumab
Dr Simon Tsoi investigated the association between body weight and tocilizumab effectiveness in rheumatoid arthritis, using data from the BSRBR-RA study. The results were published in the Rheumatology journal. What was already known?Tocilizumab is a type of treatment...
Adverse Events and the BSRBR-RA Study
How are adverse event data collected on the BSRBR-RA Study?An adverse event is “any untoward medical occurrence in a patient being administered a pharmaceutical product, which does not necessarily have a causal relationship with the product.”Details of adverse events...
Contact Us
+44 (0) 161 306 6000
Recent Comments